376.1 🎓 醫孞生版

376.1.0.1 📌 䞀頁重點

376.1.0.1.1 Definition (DSM-5)

376.1.1 Core Features

  1. Disturbance in attention + awareness (reduced ability to focus, sustain, shift attention)
  2. Develops over short period (hours to days) — represents change from baseline
  3. Fluctuates during the day
  4. Additional cognitive disturbance (memory, orientation, language, perception)
  5. NOT better explained by another neurocognitive disorder
  6. Evidence of physiological cause (medical, drug, withdrawal, toxin, multifactorial)

376.1.2 Hallmark

  • Inattention (most characteristic feature)
  • “Where is the patient’s attention?”
376.1.2.0.1 Subtypes

376.1.3 Hyperactive (25%)

  • Agitation, restlessness
  • Easier to recognize
  • Hallucinations, delusions
  • May be aggressive

376.1.4 Hypoactive (50%)

  • Lethargy, withdrawn
  • Often missed (worst prognosis)
  • Decreased response
  • Confused with depression

376.1.5 Mixed (25%)

  • Fluctuates
376.1.5.0.1 Epidemiology
  • ~ 20% hospitalized older adults
  • 50-80% ICU patients
  • 30% post-surgical elderly
  • 70% post-hip fracture
  • 90% terminal illness
376.1.5.0.2 Predisposing Factors
  • Age > 65
  • Pre-existing dementia (most important)
  • Prior delirium
  • Multi-comorbidity
  • Severe illness
  • Functional impairment
  • Sensory impairment (visual, hearing)
  • Depression
  • Substance use disorder
  • Frailty
376.1.5.0.3 Precipitating Factors

376.1.6 Medications (Most Common Cause)

  • Anticholinergics (oxybutynin, scopolamine, diphenhydramine, TCAs)
  • Benzodiazepines
  • Opioids (especially meperidine — accumulates normeperidine)
  • Sedatives
  • Antiparkinsonian (anticholinergic effect)
  • Antiepileptics (phenytoin)
  • Steroids
  • Many others

376.1.7 Infection

  • UTI (especially elderly)
  • Pneumonia
  • Sepsis
  • CNS infection
  • COVID-19 (significant)

376.1.8 Metabolic

  • Hypoglycemia, hyperglycemia
  • Hyponatremia, hypernatremia
  • Hypercalcemia, hypocalcemia
  • Hypomagnesemia
  • Uremia
  • Hepatic encephalopathy
  • Hypothyroidism, hyperthyroidism
  • Adrenal insufficiency

376.1.9 Withdrawal

  • Alcohol (DTs — delirium tremens)
  • Benzodiazepines
  • Opioids

376.1.10 Hypoxia, Hypercapnia

376.1.11 Stroke, TBI, Subdural Hematoma, Seizure (Post-Ictal)

376.1.12 Surgery + Anesthesia

  • Post-operative delirium common in elderly
  • Hip fracture (especially)
  • Cardiac surgery
  • Multifactorial

376.1.13 ICU Factors

  • Sleep deprivation
  • Sensory overload/deprivation
  • Immobilization
  • Restraints
  • Multiple medications

376.1.14 Other

  • Pain (especially undertreated)
  • Urinary retention, constipation
  • Dehydration
  • Malnutrition
  • Bedrest
  • Sleep deprivation
376.1.14.0.1 Assessment

376.1.15 Tools

  • Confusion Assessment Method (CAM):
      1. Acute onset + fluctuating + (2) Inattention + (either) (3) Disorganized thinking OR (4) Altered LOC
  • CAM-ICU: for ICU/intubated patients
  • Delirium Rating Scale
  • MMSE/MoCA: cognitive screening

376.1.16 History

  • Baseline mental status (collateral!)
  • Time course
  • Recent changes (meds, surgery, illness)
  • Functional status

376.1.17 Exam

  • Vital signs
  • General + focused neuro
  • Look for asterixis, myoclonus
  • Cranial nerves, motor, sensory

376.1.18 Labs

  • CBC
  • Electrolytes, calcium, magnesium
  • Glucose
  • BUN/Cr
  • LFTs, ammonia
  • TFTs
  • B12, folate
  • UA + culture
  • CXR
  • ECG
  • Drug levels (digoxin, lithium, ASMs)
  • Toxicology screen
  • Blood cultures if febrile

376.1.19 Imaging + Specialized

  • CT head if focal deficit, trauma, suspected stroke/bleed
  • LP if meningitis suspected
  • EEG if seizures suspected (NCSE)
376.1.19.0.1 Differential Diagnosis

376.1.20 Delirium vs Dementia

Feature Delirium Dementia
Onset Hours-days Months-years
Course Fluctuating Progressive
Consciousness Altered Clear (usually)
Attention Impaired (hallmark) Normal early
Reversibility Often reversible Usually not
Sleep-wake Disrupted Variable

376.1.21 Delirium Superimposed on Dementia

  • Very common
  • High-risk hospitalized older adults
  • Worsens prognosis

376.1.22 Other Differentials

  • Depression
  • Mania
  • Psychosis (functional)
  • Aphasia
  • Status epilepticus (NCSE)
376.1.22.0.1 Management

376.1.23 Non-Pharmacologic (FIRST-LINE)

HELP Program (Hospital Elder Life Program): - Multicomponent intervention - Reorientation (clocks, calendars, communication) - Sleep enhancement (non-pharm) - Mobilization - Visual + hearing aids - Hydration + nutrition - Pain management - Avoid restraints - Family involvement

Environmental: - Quiet, well-lit during day, dark at night - Familiar objects - Clock, calendar visible - Glasses, hearing aids - Family at bedside

Medical Optimization: - Identify + treat underlying cause(s) - Discontinue/minimize culprit drugs - Treat infection - Correct electrolytes - Manage pain (acetaminophen first; minimize opioids; avoid meperidine) - Bowel + bladder regularity - Adequate hydration + nutrition - Sleep hygiene (no daytime naps if possible, melatonin)

376.1.24 Pharmacologic (LAST RESORT)

Indications: - Severe agitation - Danger to self/others - Distress unrelieved by non-pharm - Interfering with essential medical care

Choice: - Haloperidol 0.5-1 mg PO/IM/IV (low dose, especially elderly) - Atypical antipsychotics: - Quetiapine 12.5-50 mg (preferred for PD, DLB) - Risperidone 0.25-1 mg - Olanzapine 2.5-5 mg - AVOID: - Benzodiazepines (paradoxical worsening) — EXCEPT for alcohol/BZD withdrawal - Anticholinergic agents - Caveats: - QT prolongation (haloperidol, atypicals) — check ECG - EPS, NMS, parkinsonism - Mortality black box warning in dementia - Use lowest dose, shortest duration

Alpha-2 Agonists: - Dexmedetomidine (ICU sedation) — alternative to propofol/BZDs; less delirium

376.1.25 Special Situations

Alcohol Withdrawal Delirium (DTs): - BZDs first-line (lorazepam, diazepam) - Thiamine (before glucose) - Glucose - Magnesium - Phenobarbital alternative - ICU level care for severe

ICU Delirium: - Minimize BZDs - Dexmedetomidine over BZDs - Sleep promotion - Early mobilization (ABCDEF bundle) - Daily SAT/SBT - Avoid restraints

Terminal Delirium: - Symptom management - Consider haloperidol or atypicals for distress - Family communication

376.1.25.0.1 Consequences
  • Prolonged hospital stay (5-10 days)
  • ↑ Mortality (in-hospital + post-discharge)
  • ↑ Institutionalization
  • Accelerated cognitive decline
  • ↑ Functional impairment
  • ↑ Healthcare costs
  • May persist months in some
376.1.25.0.2 Prevention
  • Multicomponent non-pharm (HELP program)
  • Geriatric consultation
  • Avoid high-risk medications
  • Pre-op optimization
  • Early mobilization post-op
  • Sleep promotion
  • Adequate analgesia (non-opioid first)

376.1.25.1 🩺 床邊速查

  • Delirium DSM-5: acute + fluctuating + inattention + cognitive + organic cause
  • Hallmark: inattention
  • Subtypes: hyperactive (25%) vs hypoactive (50% — often missed) vs mixed
  • CAM: 4 criteria
  • Common precipitants: meds (#1 anticholinergics, BZDs, opioids), infection, metabolic, withdrawal, surgery, ICU
  • Workup: CAM + meds review + labs + selective imaging
  • Treatment: non-pharm first (HELP) + treat underlying + pharm last resort (low-dose haloperidol or atypical, AVOID BZDs except withdrawal)
  • Dexmedetomidine preferred over BZDs in ICU
  • Consequences: ↑ mortality + ↑ stay + ↑ institutionalization + accelerated dementia